The Coronary AccEss After TAVR (CAvEAT) Registry: An International, Multicenter Prospective Registry of Coronary Access After TAVR
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- lecture fees <10K - Abbott; Abiomed; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; Microport